Cell line name NCC-ES2-C1
Accession CVCL_B7PH
Resource Identification Initiative To cite this cell line use: NCC-ES2-C1 (RRID:CVCL_B7PH)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~159 hours (PubMed=35441357).
Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
Sequence variations
Gene fusion; HGNC; 3508; EWSR1 + HGNC; 3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 7 fused to FLI1 exon 8 (PubMed=35441357).
Disease Ewing sarcoma (NCIt: C4817)
Ewing sarcoma (ORDO: Orphanet_319)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 17Y
Category Cancer cell line
STR profile

Source(s): PubMed=35441357


Amelogenin X,Y
CSF1PO 10,11
D5S818 10,12
D7S820 10,12
D13S317 8,10
D16S539 10
D21S11 28,30
TH01 9
TPOX 8,11
vWA 17,18

PubMed=35441357; DOI=10.1007/s13577-022-00701-9
Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Akiyama T., Nakagawa R., Kamio S., Hirabayashi K., Ozawa I., Kikuta K., Kondo T.
Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
Hum. Cell 35:1262-1269(2022)

Encyclopedic resources Wikidata; Q112930162

Additional information

Weight N/A
User Category

Academia/non-profit organization, For-profit organization


There are no reviews yet.

Be the first to review “NCC-ES2-C1”

Your email address will not be published. Required fields are marked *